MyJournals Home  

RSS FeedsCost-effectiveness analysis of atezolizumab in advanced triple-negative breast cancer (BMC Health Services Research)

 
 

24 june 2020 23:30:37

 
Cost-effectiveness analysis of atezolizumab in advanced triple-negative breast cancer (BMC Health Services Research)
 


The IMpassion130 trial demonstrated that adding atezolizumab to nanoparticle albumin-bound (nab)-paclitaxel improved the survival of patients with untreated, advanced, programmed death ligand 1 (PDL1)-positive...


 
223 viewsCategory: Medicine
 
A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis (Arthritis Research & Therapy)
Applying critical systems thinking to social prescribing: a relational model of stakeholder “buy-in” (BMC Health Services Research)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Medicine


Copyright © 2008 - 2021 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten